• Tue, January 3, 2023
  • Fri, December 30, 2022

Mayank Mamtani Maintained (TGTX) at Strong Buy with Increased Target to $23 on, Dec 30th, 2022

Mayank Mamtani of B. Riley Securities, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Increased Target from $17 to $23 on, Dec 30th, 2022.

Mayank has made no other calls on TGTX in the last 4 months.



There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 0 agree with Mayank's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mayank


  • Alec Stranahan of "B of A Securities" Maintained at Sell with Increased Target to $6 on, Thursday, December 29th, 2022
  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Thursday, December 29th, 2022

Like: 👍